SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001437749-22-005764
Filing Date
2022-03-10
Accepted
2022-03-09 20:42:08
Documents
62

Document Format Files

Seq Description Document Type Size
1 govx20220301b_posam.htm POS AM 1168507
2 ex_344097.htm EX-23.1 2853
3 govx20220301b_posamimg003.jpg GRAPHIC 6753
4 govx20220301b_posamimg001.jpg GRAPHIC 6753
5 img01.jpg GRAPHIC 3332
6 virstructure.jpg GRAPHIC 47749
  Complete submission text file 0001437749-22-005764.txt   4380528

Data Files

Seq Description Document Type Size
7 govx-20211231.xml EX-101.INS 569406
8 govx-20211231.xsd EX-101.SCH 49135
9 govx-20211231_cal.xml EX-101.CAL 32683
10 govx-20211231_def.xml EX-101.DEF 334147
11 govx-20211231_lab.xml EX-101.LAB 290691
12 govx-20211231_pre.xml EX-101.PRE 356208
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-239958 | Film No.: 22727128
SIC: 2834 Pharmaceutical Preparations